Studies have noted increased CD38+HLA-DR+CD8+ T cells in H7N9 influenza and COVID-19, particularly in critically ill cases, suggesting their prognostic value and involvement in severe immune dysregulation (36). The gene discussed is CD38; the disease is COVID-19.